SCHEMBL6880715

SCHEMBL6880715

CC1CCC(CN)(CP(=O)(O)O)C1.C[C@H]1CC(CN)(CP(=O)(O)O)C[C@@H]1C

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5382375 0.94 CYP1A2 (0.38) CYP1A2
SCHEMBL5394072 0.94 CYP1A2 (0.38) CYP1A2
SCHEMBL5382379 0.94 CYP1A2 (0.38) CYP1A2
SCHEMBL5388548 0.94 CYP1A2 (0.38) CYP1A2
SCHEMBL5394201 0.94 CYP1A2 (0.38) CYP1A2
SCHEMBL5537093 0.87 FUCA1 (0.32)
SCHEMBL5405686 0.87 FUCA1 (0.32)
SCHEMBL5390585 0.87 FUCA1 (0.32)
SCHEMBL5394130 0.87 FUCA1 (0.32)
SCHEMBL5394133 0.87 FUCA1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1469841-A1 ALPHA 2 DELTA LIGANDS TO TREAT TINNITUS WARNER-LAMBERT COMPANY (US) 2004-10-27 EP disclosed
WO-2003063845-A1 ALPHA 2 DELTA LIGANDS TO TREAT TINNITUS WARNER-LAMBERT COMPANY LLC (US) 2003-08-07 WO disclosed